H19 and hepatoblastoma: Moreover, H19 rs2839698 polymorphism was associated with significantly increased risk of hepatoblastoma (recessive model: adjusted odds ratio (OR) = 1.68, 95% confidence interval (CI) = 1.10‐2.58, P = .017).